Doctolib vs ALSAC

Nvidia invests in Doctolib, Pigment, Genesis AI, Entalpic

European tech startups raised €15.8 billion in September, nearly five times August's €3.2 billion, with the UK attracting the largest share (46%). Mega-deals included Mistral's €3 billion Series D and Nscale's $3.36 billion convertible notes; even excluding these, funding tripled month-over-month. Nvidia continued its European expansion by announcing minority investments in four French startups (Doctolib, Genesis AI, Pigment, Entalpic) and five UK startups (Boltz, Foresight, Hiverge, Prima Mente, Riverlane), as part of nearly €9 billion in European commitments. CEO Jensen Huang also announced a $250 million compute donation to UK AI safety and research. Critics question circular financing, while Huang advocates continued dialogue with Chinese AI firms. These moves follow Nvidia's recent agreement to acquire Hugging Face for about $12.9 billion.

• European startups raised €15.8 billion in September, nearly five times August's €3.2 billion.
• Nvidia announced minority investments in four French (Doctolib, Genesis AI, Pigment, Entalpic) and five UK (Boltz, Foresight, Hiverge, Prima Mente, Riverlane) startups, with total European commitment near €9 billion.
• Mistral raised €3 billion in Series D at a valuation over €21 billion, the largest equity round for a European tech company.

Nvidia Invests in Four French Tech Companies

Nvidia has announced investments in four French technology companies during Jensen Huang's visit to Paris. The companies are Doctolib, a healthcare appointment platform; Genesis AI, a robotics startup; Pigment, a financial planning software maker; and Entalpic, a materials research startup. The deals are minority stakes, but the specific amounts and equity sizes were not disclosed. Nvidia's investment in Doctolib is intended to support its development of AI agents and a digital health companion. This move is part of Nvidia's broader commitment of nearly $10 billion to Europe's tech ecosystem, with plans to announce an additional $2 billion in European deals within a week. The investments have drawn criticism over potential circular financing, where AI firms use the funds to buy Nvidia chips, but Huang rejects these claims.

• Nvidia invests in Doctolib, Genesis AI, Pigment, and Entalpic.
• The investments are minority stakes; amounts undisclosed.
• Investment in Doctolib supports its AI agent and health companion work.

St. Jude Newsroom: KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups

The St. Jude Newsroom page has been updated with several new press releases. Notable additions include: 'KDM2B revealed as a selective dependency in high-risk medulloblastoma subgroups' (09/24/2026), 'Targeting ZMYND8 improves T-cell function and may boost immunotherapy' (09/23/2026), 'U.S. News & World Report ranks St. Jude among top three outstanding pediatric cancer hospitals' (09/15/2026), 'AI-informed AdaptiveFlow redefines large-scale cloud computing for drug discovery' (09/01/2026), 'ALSAC Named to Fast Company's 2026 Best Workplaces for Innovators List' (09/10/2026), and 'Chili's® Announces Historic $150 Million Commitment to St. Jude Children's Research Hospital®' (09/08/2026).

Chili’s® Announces Historic $150 Million Commitment to St. Jude Children’s Research Hospital®

Chili’s® Grill & Bar made a new pledge to help raise $150 million over the next 15 years to help support children and families facing cancer and other life-threatening diseases at St. Jude.